TWD 156.0
(-9.83%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 655.52 Million TWD | 118.39% |
2022 | 300.16 Million TWD | -30.72% |
2021 | 433.26 Million TWD | 513.84% |
2020 | -104.69 Million TWD | 15.16% |
2019 | -102.52 Million TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 45.71 Million TWD | -66.07% |
2024 Q2 | 138.77 Million TWD | 203.55% |
2023 Q4 | 134.73 Million TWD | -57.1% |
2023 FY | - TWD | 118.39% |
2023 Q2 | 76.59 Million TWD | -41.13% |
2023 Q1 | 130.1 Million TWD | 25.22% |
2023 Q3 | 314.09 Million TWD | 310.08% |
2022 FY | - TWD | -30.72% |
2022 Q4 | 103.9 Million TWD | 0.0% |
2021 FY | - TWD | 513.84% |
2020 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 1517.529% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | -66.543% |
Level Biotechnology Inc. | 98.7 Million TWD | -564.129% |
Sagittarius Life Science Corp | -44.73 Million TWD | 1565.214% |
NeoCore Technology Co., Ltd. | -72.11 Million TWD | 1008.995% |
TaiMed Biologics Inc. | -25.23 Million TWD | 2697.876% |
GlycoNex Incorporation | -126.82 Million TWD | 616.863% |
VBI | -6.97 Million TWD | 9502.209% |
GeneReach Biotechnology Corp. | -143.69 Million TWD | 556.19% |
Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -2905.603% |
SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 3798.082% |
Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 732.652% |
Visgeneer Inc. | 973 Thousand TWD | -67271.223% |
Mycenax Biotech Inc. | -339.48 Million TWD | 293.094% |
Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 30.001% |
G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | -556.592% |
Neith Corporation | -33.61 Million TWD | 2050.378% |
Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 166.141% |
TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 37838.745% |
Enimmune corporation | -228.96 Million TWD | 386.3% |
TaiRx, Inc. | -208.64 Million TWD | 414.179% |
CHO Pharma, Inc. | -277.73 Million TWD | 336.028% |
EirGenix Inc. | -664.4 Million TWD | 198.663% |
BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | -786.991% |
Sunny Pharmtech Inc. | 69.14 Million TWD | -848.067% |
Lin BioScience, Inc. | -1.07 Billion TWD | 161.184% |
BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 679.564% |
Feng Chi Biotech Corp. | 34.83 Million TWD | -1781.629% |
Bio Preventive Medicine Corp. | -62.34 Million TWD | 1151.51% |
Lukas Biomedical Inc. | -26.3 Million TWD | 2592.479% |
RBC Bioscience Corporation | 36.54 Million TWD | -1693.641% |
BiOptic Inc. | 65.03 Million TWD | -907.906% |
BRIM Biotechnology, Inc. | -682.46 Million TWD | 196.053% |
Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 2086.069% |
Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 1293.703% |
Syngen Biotech Co.,Ltd. | 433.55 Million TWD | -51.197% |
Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 918.666% |
NaviFUS Corp. | -55.79 Million TWD | 1274.876% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 4049.404% |
Sinew Pharma Inc. | -163.63 Million TWD | 500.61% |
Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 1165.889% |
Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | -240.704% |
Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 389.186% |
AP Biosciences Inc | -325.51 Million TWD | 301.381% |
Medigen Biotechnology Corp. | -1.04 Billion TWD | 162.752% |
3D Global Biotech Inc. | -35.84 Million TWD | 1928.717% |
Pharmosa Biopharm Inc. | 29.13 Million TWD | -2150.333% |
Intech Biopharm Corporation | -219.58 Million TWD | 398.528% |
Oneness Biotech Co., Ltd. | -674.22 Million TWD | 197.225% |
Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 1558.303% |
TWi Biotechnology, Inc. | -160.85 Million TWD | 507.518% |
TCI GENE Inc. | 25.98 Million TWD | -2423.082% |
MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 692.493% |
Senhwa Biosciences, Inc. | -283.78 Million TWD | 330.992% |
Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 549.08% |
NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -4633.011% |
PharmaEngine, Inc. | 347.3 Million TWD | -88.745% |
Savior Lifetec Corporation | 219.6 Million TWD | -198.5% |
TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | -280.608% |
OBI Pharma, Inc. | -855.08 Million TWD | 176.662% |
Meribank Biotech Co., Ltd | -92.56 Million TWD | 808.19% |
Acepodia, Inc. | -764.51 Million TWD | 185.743% |
Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 242.477% |